Primary Record
Endoxifen
- In stock
- 3,823 g
- Purity
- 98.7 %
- CAS
- 112093-28-4
Compound Identifiers & Properties
- CAS
- 112093-28-4
- PubChem CID
- 10090750
- SMILES
- CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3
- Canonical SMILES
- CC/C(=C(\c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1
Names & Synonyms
- Endoxifen
- Z-Endoxifen
- Endoxifen Z-Isomer
- (Z)-Endoxifen
- (E/Z)-Endoxifen
- 112093-28-4
- 4OHNDtam
- 4-Hydroxy-N-desmethyltamoxifen
- Endoxifen?
- Racemic Endoxifen
- EndoxifenZ-Isomer
- N-Desmethyl-4-hydroxytamoxifen
- (Z)-Endoxyfen
- Endoxifen (Z-isomer)
- ENDOXIFEN [WHO-DD]
- UNII-46AF8680RC
- Endoxifen(E/Z=1:1)
- RefChem:590841
- 4-Hydroxy-N-demethyltamoxifen
- D0W4EB
- 110025-28-0
- 4-hydroxy-N-desmethyl tamoxifen
- 4-Hydroxy-N-desmethyl-tamoxifen
- C25H27NO2
- NSC-749798
- MFCD09840374
- 46AF8680RC
- orb1305808
- CHEMBL1093458
- SCHEMBL10107920
- CHEBI:80555
- GTPL10203
- DTXSID80149880
- EX-A645
- MHJBZVSGOZTKRH-IZHYLOQSSA-N
- 4 -Hydroxy-N-desmethyltamoxifen
- NSC 749798
- BCP15866
- EX-A1970
- (Z)-4-Hydroxy-N-desmethyl Tamoxifen (mixture of isomers)
- BDBM50435003
- C25-H27-N-O2
- EBC-13769
- HY-18719E
- MSK300575
- NSC746494
- NSC749798
- NSC777380
- NSC833479
- ZINC22056306
- AKOS030526256
- ACN-053042
- FE15969
- NSC-746494
- NSC-777380
- NSC-833479
- 4-hydroxy-N-desmethyltamoxifen, (Z)-isomer
- CID10090750
- Endoxifen (topical formulation, cancer)
- NCGC00386714-01
- AC-36810
- BE172975
- BS-42369
- J393.650C
- B7481
- CS-0028594
- FT-0669525
- N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture)
- NS00093647
- X5886
- (Z)-4-Hydroxy-N-desmethyl Tamoxifen (contains up to 10% E isomer)
- 4-[(Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
- C16547
- EN300-822190
- A894656
- N-Desmethyl-4-hydroxytamoxifen, mixture of isomers
- (Z)-4-(1-(4-(2-(methylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol
- 4-[(1Z)-1-{4-[2-(methylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenol
- BRD-K62752296-003-01-3
- Q27149598
- 4-[1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
- B2694-257357
- N-Desmethyl-4-hydroxy tamoxifen(approx. 1:1 e/z mixture)
- 4-(1-(4-(2-(methylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol
- 4-[(~{Z})-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
- Endoxifen (topical formulation, cancer), Jina Pharmaceuticals
- Phenol, 4-(1-(4-(2-(methylamino)ethoxy]phenyl)-2-phenyl-1-butenyl)-, (Z)-
- (E/Z)-4-[1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-phenol
- (Z)-4-Hydroxy-N-desmethyl tamoxifen(contains up to 10% e isomer)
- (E/Z)-4-(1-(4-(2-(methylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol
- (Z)-4-(1-(4-(2-(methylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol
- 4-((~(Z))-1-(4-(2-(methylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol
- 4-[(Z)-1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol
- 4-[(Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-but-1-enyl]phenol
- 4-[1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol
- 4-[1-[4-[2-(METHYLAMINO)ETHOXY]PHENYL]-2-PHENYL-1-BUTENYL]PHENOL
- E/Z-1-(4-hydroxyphenyl)-1-[4-(2-methylaminoethoxy)phenyl]-2-phenylbutene
- N-Desmethyl-4-hydroxytamoxifen, mixture of isomers, analytical standard
- Tamoxifen metabolite (topical formulation, cancer), Jina Pharmaceuticals
- 4-[(1Z)-1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol
- phenol, 4-((1Z)-1-(4-(2-(methylamino)ethoxy)phenyl)-2-phenyl-1-buten-1-yl)-
- Phenol, 4-[(1Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-
- 114828-90-9
- 4-[1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol; (E/Z)-Endoxifen; 4OHNDtam;